中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Advances in drug screening methods relative to androgen and estrogen receptors

文献类型:期刊论文

作者Mou Lingyun; Wang Mingwei
刊名Chinese Bulletin of Life Sciences
出版日期2004
卷号16期号:5页码:305-311
关键词androgen receptor estrogen receptor selective receptor modulator
ISSN号1004-0374
其他题名雄激素和雌激素受体药物筛选方法的研究进展
文献子类Article
英文摘要Androgen and estrogen stimulate cell differentiation and tissue growth through specific interactions with respective receptor (AR or ER), thereby playing critical roles in numerous physiological processes. Dysfunctions of either hormones or receptors lead to various diseases. Selective AR or ER modulators possess ideal pharmacological profiles in disease treatment. Based upon the latest developments in genomics, molecu-lar biology, cellular biology and bioinformatics, etc., new technologies or experimental methods have been applied to screen novel selective AR or ER modulators and thus, significantly accelerated the pace of drug discovery.
资助项目国家自然科学基金项目[00000000]
WOS研究方向Pharmacology & Pharmacy (provided by Clarivate Analytics)
语种中文
CSCD记录号CSCD:1701596
源URL[http://119.78.100.183/handle/2S10ELR8/268409]  
专题国家新药筛选中心
作者单位The National Center for Drug Screening, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 201203, China.
推荐引用方式
GB/T 7714
Mou Lingyun,Wang Mingwei. Advances in drug screening methods relative to androgen and estrogen receptors[J]. Chinese Bulletin of Life Sciences,2004,16(5):305-311.
APA Mou Lingyun,&Wang Mingwei.(2004).Advances in drug screening methods relative to androgen and estrogen receptors.Chinese Bulletin of Life Sciences,16(5),305-311.
MLA Mou Lingyun,et al."Advances in drug screening methods relative to androgen and estrogen receptors".Chinese Bulletin of Life Sciences 16.5(2004):305-311.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。